


The objective of the Fund is to achieve absolute returns through targeted investment strategies independent of United Kingdom market conditions or indices.
| Name | % Net Assets |
|---|---|
| Babcock Intl Group Ord Gbp0.60 | 6.4% |
| Melrose Ord Gbp0.002 | 6.1% |
| GLAXOSMITHKLINE | 4.3% |
| RSA INSURANCE GROUP PLC | 4.0% |
| IMPERIAL TOBACCO GROUP | 3.1% |
| HOWDEN JOINERY GROUP PLC | 3.1% |
| MORRISON(WM.)SUPERMARKETS | 2.8% |
| MORGAN CRUCIBLE CO | 2.6% |
| Astrazeneca Ord Usd0.25 | 2.3% |
| Compass Group Ord Gbp0.10 | 2.1% |
| Key | % Net Assets |
|---|---|
| 6.4% | |
| 6.1% | |
| 4.3% | |
| 4.0% | |
| 79.2% |
| Date | 15-Jun-2020 |
|---|---|
| NAV | 1.05p |
| Currency | GBP |
| Change | 0.009p |
| % | -0.85% |
| YTD change | 1.05p |
| YTD % | n/a |
| Fund Inception | 18/07/2008 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research